Corbin Therapeutics

Corbin Therapeutics is a company that develops an in-vivo genome-wide screening platform in mice undergoing experimental neuro-inflammation. It aims to promote the development of ubiquitin-specific protease 15 (USP15) inhibitors in neuroinflammation-based disorders, such as multiple sclerosis.